CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes

Journal of Experimental Medicine

Volumn 199, Issue 11, 2004, Pages 1467-1477

  Tarbell, Kristin V ^a   Yamazaki, Sayuri ^a   Olson, Kara ^a   Toy, Priscilla ^a   Steinman, Ralph M ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Autoimmunity; BDC2.5; CD25+ CD4+ regulatory T cells; Dendritic cells; Insulin dependent diabetes mellitus

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR; PEPTIDE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; DENDRITIC CELL; DIABETES MELLITUS; IMMUNE SYSTEM; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SUPPRESSOR CELL; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD4; AUTOANTIGENS; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; FEMALE; IMMUNOPHENOTYPING; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED NOD; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, REGULATORY;

EID: 2942692039     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20040180     Document Type: Article

References (54)

1. Tisch, R., and H. McDevitt. 1996. Insulin-dependent diabetes mellitus. Cell. 85:291-297.
2. Wong, F.S., and C.A. Janeway, Jr. 1999. Insulin-dependent diabetes mellitus and its animal models. Curr. Opin. Immunol. 11:643-647.
3. Makino, S., K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino. 1980. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu. 29:1-13.
4. Tisch, R., X.-Y. Yang, S.M. Singer, R.S. Libiau, L. Fugger, and H.O. McDevitt. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 366:72-75.
5. Daniel, D., R.G. Gill, N. Schloot, and D. Wegmann. 1995. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25:1056-1062.
6. + T cells in autoimmune diabetes. Proc. Natl. Acad. Sci. USA. 100:8384-8388.
7. Roep, B.O. 1996. T-cell responses to autoantigens in IDDM. The search for the Holy Grail. Diabetes. 45:1147-1156.
8. Verge, C.F., R. Gianani, E. Kawasaki, L. Yu, M. Pietropaolo, H.P. Chase, and G.S. Eisenbarth. 1996. Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes. J. Autoimmun. 9:379-383.
9. Walker, L.S.K., and A.K. Abbas. 2002. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat. Rev. Immunol. 2:11-19.
10. Asano, M., M. Toda, N. Sakaguchi, and S. Sakaguchi. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184:387-396.
11. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160:1212-1218.
12. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182:18-32.
13. Saoudi, A., B. Seddon, D. Fowell, and D. Mason. 1996. The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients. J. Exp. Med. 184:2393-2398.
14. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-1164.
15. + regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J. Immunol. 168:5979-5983.
16. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor foxp3. Science. 299:1057-1061.
17. + T regulatory cells. Nat. Immunol. 4:337-342.
18. + regulatory T cells. Nat. Immunol. 4:330-336.
19. Wildin, R.S., F. Ramsdell, J. Peake, F. Faravelli, J.L. Casanova, N. Buist, E. Levy-Lahad, M. Mazzella, O. Goulet, L. Perroni, et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27:18-20.
20. Bennett, C.L., J. Christie, F. Ramsdell, M.E. Brunkow, P.J. Ferguson, L. Whitesell, T.E. Kelly, F.T. Saulsbury, P.F. Chance, and H.D. Ochs. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27:20-21.
21. + immunoregulatory T cells that control autoimmune diabetes. Immunity. 12:431-440.
22. + splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169:2461-2465.
23. Wu, Q., B. Salomon, M. Chen, Y. Wang, L.M. Hoffman, J.A. Bluestone, and Y.X. Fu. 2001. Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor. J. Exp. Med. 193:1327-1332.
24. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10:1969-1980.
25. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287-296.
26. + regulatory T cells by antigen processing dendritic cells. J. Exp. Med. 198:235-247.
27. + regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature DCs in vivo. J. Exp. Med. 198:259-266.
28. + regulatory T cells in vivo. J. Exp. Med. 198:249-258.
29. + regulatory T cells in the steady state. J. Exp. Med. 198:737-746.
30. Klein, L., K. Khazaie, and H. Von Boehmer. 2003. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA. 100:8886-8891.
31. + regulatory T cells. J. Immunol. 170:3939-3943.
32. + regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc. Natl. Acad. Sci. USA. 99:8213-8218.
33. Katz, J.D., B. Wang, K. Haskins, C. Benoist, and D. Mathis. 1993. Following a diabetogenic T cell from genesis through pathogenesis. Cell. 74:1089-1100.
34. Prasad, S.J., and C.C. Goodnow. 2002. Cell-intrinsic effects of non-MHC NOD genes on dendritic cell generation in vivo. Int. Immunol. 14:677-684.
35. Prasad, S.J., and C.C. Goodnow. 2002. Intrinsic in vitro abnormalities in dendritic cell generation caused by non-MHC non-obese diabetic genes. Immunol. Cell Biol. 80:198-206.
36. + T cell levels in NOD mice. Proc. Natl. Acad. Sci. USA. 99:12287-12292.
37. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R.M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693-1702.
38. Judkowski, V., C. Pinilla, K. Schroder, L. Tucker, N. Sarvetnick, and D.B. Wilson. 2001. Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice. J. Immunol. 166:908-917.
39. Hoglund, P., J. Mintern, C. Waltzinger, W. Heath, C. Benoist, and D. Mathis. 1999. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J. Exp. Med. 189:331-339.
40. Feili-Hariri, M., and P.A. Morel. 2001. Phenotypic and functional characteristics of BM-derived DC from NOD and non-diabetes-prone strains. Clin. Immunol. 98:133-142.
41. Andre-Schmutz, I., C. Hindelang, C. Benoist, and D. Mathis. 1999. Cellular and molecular changes accompanying the progression from insulitis to diabetes. Eur. J. Immunol. 29:245-255.
42. + T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes. 42:44-55.
43. Rohane, P.W., A. Shimada, D.T. Kim, C.T. Edwards, B. Charlton, L.D. Shultz, and C.G. Fathman. 1995. Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice. Diabetes. 44:550-554.
44. Gregori, S., N. Giarratana, S. Smiroldo, and L. Adorini. 2003. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J. Immunol. 171:4040-4047.
45. + T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer. J. Exp. Med. 196:481-492.
46. Verdaguer, J., D. Schmidt, A. Amrani, B. Anderson, N. Averill, and P. Santamaria. 1997. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186:1663-1676.
47. Berzins, S.P., E.S. Venanzi, C. Benoist, and D. Mathis. 2003. T-cell compartments of prediabetic NOD mice. Diabetes. 52:327-334.
48. Kukreja, A., G. Cost, J. Marker, C. Zhang, Z. Sun, K. Lin-Su, S. Ten, M. Sanz, M. Exley, B. Wilson, et al. 2002. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 109:131-140.
49. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162:5317-5326.
50. Suto, A., H. Nakajima, K. Ikeda, S. Kubo, T. Nakayama, M. Taniguchi, Y. Saito, and I. Iwamoto. 2002. CD4(+)CD25(+) T-cell development is regulated by at least 2 distinct mechanisms. Blood. 99:555-560.
51. Andre, I., A. Gonzalez, B. Wang, J. Katz, C. Benoist, and D. Mathis. 1996. Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc. Natl. Acad. Sci. USA. 93:2260-2263.
52. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 164:183-190.
53. R cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197:111-119.
54. Arif, S., T.I. Tree, T.P. Astill, J.M. Tremble, A.J. Bishop, C.M. Dayan, B.O. Roep, and M. Peakman. 2004. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J. Clin. Invest. 113:451-463.